Skip to main content

Scynexis Inc

SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001178253

No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Scynexis Inc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of SCYX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3942+3
Shares11.1M11.8M+666.1K (+6.0%)
Value$7.49M$9.06M+$1.57M (+21.0%)

New holders (7)

Institutions that held Scynexis Inc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to SCYX in Q3 2025
InstitutionSharesValue% of portfolio
Sequoia Financial Advisors, LLC52,850$40.7K0.00%
PDS Planning, Inc15,000$11.6K0.00%
Wealth Enhancement Advisory Services, LLC14,201$11.3K0.00%
Creative Planning10,271$7.91K0.00%
Citigroup Inc6,282$4.84K0.00%
Wealthspire Advisors, LLC3,000$2.31K0.00%
Royal Bank of Canada110$00.00%

Sold out (4)

Institutions that held Scynexis Inc at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of SCYX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Susquehanna International Group, LLP58,728$39.6K
Jane Street Group, LLC39,496$26.7K
XTX Topco Ltd24,904$16.8K
Atlantic Union Bankshares Corp4,000$2.70K